Global β-Nicotinamide Mononucleotide (NMN) Market Growth 2022-2028
As the global economy mends, the 2021 growth of β-Nicotinamide Mononucleotide (NMN) will have significant change from previous year. According to our latest study, the global β-Nicotinamide Mononucleotide (NMN) market size is USD million in 2022 from USD 249.7 million in 2021, with a change of % between 2021 and 2022. The global β-Nicotinamide Mononucleotide (NMN) market size will reach USD 448.2 million in 2028, growing at a CAGR of 8.7% over the analysis period.
The United States β-Nicotinamide Mononucleotide (NMN) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global β-Nicotinamide Mononucleotide (NMN) market, reaching US$ million by the year 2028. As for the Europe β-Nicotinamide Mononucleotide (NMN) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main β-Nicotinamide Mononucleotide (NMN) players cover GeneHarbor, Herbalmax, Genex Formulas, and Shinkowa Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of β-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.
Segmentation by content: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Above 98%
Below 98%
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Health Care Products
Cosmetics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global β-Nicotinamide Mononucleotide (NMN) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for β-Nicotinamide Mononucleotide (NMN) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for β-Nicotinamide Mononucleotide (NMN) by Country/Region, 2017, 2022 & 2028
2.2 β-Nicotinamide Mononucleotide (NMN) Segment by Content
2.2.1 Above 98%
2.2.2 Below 98%
2.3 β-Nicotinamide Mononucleotide (NMN) Sales by Content
2.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2022)
2.3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Content (2017-2022)
2.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Content (2017-2022)
2.4 β-Nicotinamide Mononucleotide (NMN) Segment by Application
2.4.1 Health Care Products
2.4.2 Cosmetics
2.4.3 Others
2.5 β-Nicotinamide Mononucleotide (NMN) Sales by Application
2.5.1 Global β-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2017-2022)
2.5.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2017-2022)
2.5.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2017-2022)
3 Global β-Nicotinamide Mononucleotide (NMN) by Company
3.1 Global β-Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
3.1.1 Global β-Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2020-2022)
3.1.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2020-2022)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2020-2022)
3.2.1 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2022)
3.2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2020-2022)
3.3 Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Product Location Distribution
3.4.2 Players β-Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for β-Nicotinamide Mononucleotide (NMN) by Geographic Region
4.1 World Historic β-Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2017-2022)
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region
4.2 World Historic β-Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2017-2022)
4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2017-2022)
4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region
4.3 Americas β-Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC β-Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe β-Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Growth
5 Americas
5.1 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Country
5.1.1 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022)
5.1.2 Americas β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022)
5.2 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Content
5.3 Americas β-Nicotinamide Mononucleotide (NMN) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Region
6.1.1 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022)
6.1.2 APAC β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022)
6.2 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Content
6.3 APAC β-Nicotinamide Mononucleotide (NMN) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe β-Nicotinamide Mononucleotide (NMN) by Country
7.1.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022)
7.1.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022)
7.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Content
7.3 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) by Country
8.1.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022)
8.1.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022)
8.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Content
8.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of β-Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of β-Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of β-Nicotinamide Mononucleotide (NMN)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 β-Nicotinamide Mononucleotide (NMN) Distributors
11.3 β-Nicotinamide Mononucleotide (NMN) Customer
12 World Forecast Review for β-Nicotinamide Mononucleotide (NMN) by Geographic Region
12.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
12.1.1 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Region (2023-2028)
12.1.2 Global β-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Content
12.7 Global β-Nicotinamide Mononucleotide (NMN) Forecast by Application
13 Key Players Analysis
13.1 GeneHarbor
13.1.1 GeneHarbor Company Information
13.1.2 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Offered
13.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GeneHarbor Main Business Overview
13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
13.2.1 Herbalmax Company Information
13.2.2 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Offered
13.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Herbalmax Main Business Overview
13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
13.3.1 Genex Formulas Company Information
13.3.2 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Offered
13.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Genex Formulas Main Business Overview
13.3.5 Genex Formulas Latest Developments
13.4 Shinkowa Pharmaceutical
13.4.1 Shinkowa Pharmaceutical Company Information
13.4.2 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Offered
13.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Shinkowa Pharmaceutical Main Business Overview
13.4.5 Shinkowa Pharmaceutical Latest Developments
13.5 Maac10 Formulas
13.5.1 Maac10 Formulas Company Information
13.5.2 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Offered
13.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Maac10 Formulas Main Business Overview
13.5.5 Maac10 Formulas Latest Developments
13.6 EffePharm
13.6.1 EffePharm Company Information
13.6.2 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Offered
13.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 EffePharm Main Business Overview
13.6.5 EffePharm Latest Developments
13.7 Bontac
13.7.1 Bontac Company Information
13.7.2 Bontac β-Nicotinamide Mononucleotide (NMN) Product Offered
13.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bontac Main Business Overview
13.7.5 Bontac Latest Developments
13.8 CELFULL
13.8.1 CELFULL Company Information
13.8.2 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Offered
13.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 CELFULL Main Business Overview
13.8.5 CELFULL Latest Developments
13.9 Kingdomway
13.9.1 Kingdomway Company Information
13.9.2 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Offered
13.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Kingdomway Main Business Overview
13.9.5 Kingdomway Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. β-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. β-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Above 98%
Table 4. Major Players of Below 98%
Table 5. Global β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 6. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2022)
Table 7. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Content (2017-2022) & ($ million)
Table 8. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2022)
Table 9. Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Content (2017-2022) & (US$/Kg)
Table 10. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 11. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2022)
Table 12. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022)
Table 13. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2022)
Table 14. Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global β-Nicotinamide Mononucleotide (NMN) Sales by Company (2020-2022) & (Kg)
Table 16. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2020-2022)
Table 17. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2020-2022)
Table 19. Global β-Nicotinamide Mononucleotide (NMN) Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 21. Players β-Nicotinamide Mononucleotide (NMN) Products Offered
Table 22. β-Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global β-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2017-2022)
Table 27. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global β-Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2017-2022)
Table 31. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 34. Americas β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2022)
Table 35. Americas β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2022)
Table 37. Americas β-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2022) & (Kg)
Table 38. Americas β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2022)
Table 39. Americas β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 40. Americas β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2022)
Table 41. APAC β-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg)
Table 42. APAC β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2022)
Table 43. APAC β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2022)
Table 45. APAC β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 46. APAC β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2022)
Table 47. APAC β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 48. APAC β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2022)
Table 49. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 50. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2022)
Table 51. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2022)
Table 53. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2022) & (Kg)
Table 54. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2022)
Table 55. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 56. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Content (2017-2022) & (Kg)
Table 62. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content (2017-2022)
Table 63. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of β-Nicotinamide Mononucleotide (NMN)
Table 66. Key Market Challenges & Risks of β-Nicotinamide Mononucleotide (NMN)
Table 67. Key Industry Trends of β-Nicotinamide Mononucleotide (NMN)
Table 68. β-Nicotinamide Mononucleotide (NMN) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. β-Nicotinamide Mononucleotide (NMN) Distributors List
Table 71. β-Nicotinamide Mononucleotide (NMN) Customer List
Table 72. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region
Table 74. Global β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Content (2023-2028) & (Kg)
Table 85. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Content (2023-2028)
Table 86. Global β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Content (2023-2028) & ($ Millions)
Table 87. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Content (2023-2028)
Table 88. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global β-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2023-2028)
Table 92. GeneHarbor Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 93. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 94. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. GeneHarbor Main Business
Table 96. GeneHarbor Latest Developments
Table 97. Herbalmax Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 98. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 99. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Herbalmax Main Business
Table 101. Herbalmax Latest Developments
Table 102. Genex Formulas Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 103. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 104. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Genex Formulas Main Business
Table 106. Genex Formulas Latest Developments
Table 107. Shinkowa Pharmaceutical Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 108. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 109. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Shinkowa Pharmaceutical Main Business
Table 111. Shinkowa Pharmaceutical Latest Developments
Table 112. Maac10 Formulas Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 113. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 114. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Maac10 Formulas Main Business
Table 116. Maac10 Formulas Latest Developments
Table 117. EffePharm Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 118. EffePharm β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 119. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. EffePharm Main Business
Table 121. EffePharm Latest Developments
Table 122. Bontac Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 123. Bontac β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 124. Bontac β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Bontac Main Business
Table 126. Bontac Latest Developments
Table 127. CELFULL Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 128. CELFULL β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 129. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. CELFULL Main Business
Table 131. CELFULL Latest Developments
Table 132. Kingdomway Basic Information, β-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 133. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Offered
Table 134. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Kingdomway Main Business
Table 136. Kingdomway Latest Developments
List of Figures
Figure 1. Picture of β-Nicotinamide Mononucleotide (NMN)
Figure 2. β-Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. β-Nicotinamide Mononucleotide (NMN) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Above 98%
Figure 10. Product Picture of Below 98%
Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Content in 2021
Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Content (2017-2022)
Figure 13. β-Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2017-2022) & (Kg)
Figure 15. β-Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2017-2022) & (Kg)
Figure 17. β-Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 18. Global β-Nicotinamide Mononucleotide (NMN) Market: Others (2017-2022) & (Kg)
Figure 19. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2022)
Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2021
Figure 21. β-Nicotinamide Mononucleotide (NMN) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2021
Figure 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2021
Figure 25. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2022)
Figure 26. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region in 2021
Figure 27. Americas β-Nicotinamide Mononucleotide (NMN) Sales 2017-2022 (Kg)
Figure 28. Americas β-Nicotinamide Mononucleotide (NMN) Revenue 2017-2022 ($ Millions)
Figure 29. APAC β-Nicotinamide Mononucleotide (NMN) Sales 2017-2022 (Kg)
Figure 30. APAC β-Nicotinamide Mononucleotide (NMN) Revenue 2017-2022 ($ Millions)
Figure 31. Europe β-Nicotinamide Mononucleotide (NMN) Sales 2017-2022 (Kg)
Figure 32. Europe β-Nicotinamide Mononucleotide (NMN) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales 2017-2022 (Kg)
Figure 34. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue 2017-2022 ($ Millions)
Figure 35. Americas β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2021
Figure 36. Americas β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2021
Figure 37. United States β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2021
Figure 42. APAC β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Regions in 2021
Figure 43. China β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2021
Figure 50. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2021
Figure 51. Germany β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country in 2021
Figure 58. Egypt β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country β-Nicotinamide Mononucleotide (NMN) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of β-Nicotinamide Mononucleotide (NMN) in 2021
Figure 64. Manufacturing Process Analysis of β-Nicotinamide Mononucleotide (NMN)
Figure 65. Industry Chain Structure of β-Nicotinamide Mononucleotide (NMN)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
